top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Autore Vermehren Charlotte
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (224 p.)
Soggetto topico Manufacturing industries
Medicine and Nursing
Soggetto non controllato 2019 Beers criteria
5'nuclease assay
80 and over
abacavir
acute kidney injury
adverse drug reaction
adverse drug reactions
aged
allopurinol
antidepressants
antiepileptic drugs
antipsychotics
appropriateness
bleeding
children
chronic
clinical pharmacist
clozapine
CNV
copy number variation
cost-effectiveness
CYP1A2
CYP2D6
CYP2D7P
CYP2D8P
cytochrome P450
cytochromes
deprescribing
deprescriptions
determinants
digital decision-support
digital health
DOACs
drug hypersensitivity
drug information service
drug interaction checkers
drug metabolization
drug-drug interactions
drug-gene interactions
early biomarker
electronic medical record
electronic prescribing
emergency department
Ethiopia
exosomes
extracellular vesicles
flucloxacillin
general practice
genotyping
health outcomes
health services research
high resolution melting
HLA
hospital pharmacy service
HRM
loxapine
medication adherence
medication optimization
medication reconciliation
medication review
medication-based risk score
microvesicles
multimorbidity
nursing homes
olanzapine
older adults
older patients
outpatient
personalized medicine
persons with diabetes
pharmacogene expression
pharmacogenetics
pharmacogenomics
phenprocoumon
plasma neutrophil gelatinase-associated lipocalin
polypharmacy
population-based
potentially inappropriate medication use
prevalence
process evaluation
quality of life
shared medication record
SLCO1B1
soluble urokinase plasminogen activator receptor
thromboembolism
utility
youth
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Record Nr. UNINA-9910595072903321
Vermehren Charlotte  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug-Drug Interactions
Drug-Drug Interactions
Autore Kim Dong Hyun
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (242 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato (‒)-sophoranone
1A2
2B6
2C19
2C8
2C9
2D6
3A4
ADME
adverse drug reactions
biflavonoid
chronic kidney disease
competitive inhibition
computational prediction
CYP
CYP1A1
CYP1A2
CYP2C9
CYP2D6
CYP3A
CYP3A4
cytochrome P450
cytochromes P450
DDI
Dexamethasone
drug interaction
drug interactions
drug metabolism
drug transporter
drug-drug interaction
drug-drug interactions
expression
fexofenadine
gepants
high plasma protein binding
in silico
in vitro
in vivo
inhibitor
ixazomib
Ketoconazole
lasmiditan
Lexicomp
low permeability
Loxoprofen
mechanism-based inhibition
metabolic DDI
metabolism
migraine
monoclonal antibodies
non-competitive inhibition
O-desmethyltramadol
OATP1B1
OATP1B3
organic anion transporting polypeptide 1A2 (OATP1A2)
P-glycoprotein (P-gp)
P450
pharmacokinetics
physiologically-based pharmacokinetics
plasma concentration
polypharmacy
potent inhibition
QSAR
regulation
Rumex acetosa
selamariscina A
signal detection algorithms
spontaneous reporting systems
subset analysis
substrate
systemic exposure
tadalafil
ticagrelor
tissue-specific
tramadol
tyrosine kinase inhibitors
ubiquitination
uridine 5'-diphosphoglucuronosyl transferase
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557666403321
Kim Dong Hyun  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Regional Intestinal Drug Absorption : Biopharmaceutics and Drug Formulation
Regional Intestinal Drug Absorption : Biopharmaceutics and Drug Formulation
Autore Gonzalez-Alvarez Maria Isabel
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (238 p.)
Soggetto topico Manufacturing industries
Medicine and Nursing
Soggetto non controllato absorption-modifying excipients
BCS class IV drugs
BCS drugs
bioequivalence
biomimetic membrane
biopharmaceutics
biopharmaceutics classification system
Biopharmaceutics Classification System
clinical studies
colon absorption
combined zero- and first-order absorption
controlled release drug product
DDI
disintegration
dissolution
dissolution test
drug absorption
drug permeability
drug solubility
drug solubility/dissolution
drug-drug interactions
energy intake
enteric-coated
first-order absorption
first-pass effect
Franz cell
Franz-PAMPA
furosemide
gastrointestinal
gastrointestinal hormone
GastroPlus
hierarchical support vector regression (HSVR)
human colon carcinoma cell layer (Caco-2)
ibuprofen
ICH
in silico modeling
in situ perfusion
in vitro
in vitro in vivo extrapolations
intestinal absorption
intestinal perfusion
intestinal permeability
IVIVE
location-dependent absorption
manometry
mechanistic modeling
microdevices
mucoadhesion
nutrient absorption
nutrient digestion
obesity
oral absorption
oral drug delivery
oral peptide delivery
passive drug transport
PBBM
PBPK
permeation enhancers
pharmaceutical development
pharmacokinetics
Phoenix WinNonlin
physiologically-based pharmacokinetic (PBPK) modeling
postprandial glycaemia
pravastatin
quality control
region of the gut
regional intestinal permeability
regional/segmental-dependent permeability and absorption
route-dependent intestinal metabolism
segmental-dependent intestinal permeability
segregated flow intestinal model (SFM)
shape
traditional model (TM)
transit compartment absorption model
type 2 diabetes
zero-order absorption
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Regional Intestinal Drug Absorption
Record Nr. UNINA-9910566462603321
Gonzalez-Alvarez Maria Isabel  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Tuberculosis Drug Discovery and Development 2019
Tuberculosis Drug Discovery and Development 2019
Autore Riccardi Giovanna
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (296 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato anti-TB drug pipeline
anti-virulence compounds
antibiotic
antimicrobial drug resistance (AMR)
antimycobacterial
antituberculosis agents
artificial pneumothorax
BCG
bedaquiline
biomarkers
Carlo Forlanini
caseum
cell envelope
clinical studies
clinical trial
CTVD
delpazolid
discovery
DNA gyrase
dormancy
DprE1 inhibitor
drug combination
drug development
drug discovery
drug resistance
drug-drug interactions
EDCTP
electron transport chain
energy metabolism
genomics
granulomas
host-directed therapy
IAVI
in vitro
in vivo
isoniazid
lead generation
lipidomics
macozinone
mechanism of action
mechanisms of resistance
metabolomics
MID3
mode of action
multi-drug resistance
mutations
mycobacteria
mycobacterium
Mycobacterium tuberculosis
n/a
oxidative phosphorylation
pharmacodynamics
pharmacokinetics
phenotypic screening
PknB
PknG
post-treatment sequelae
privileged targets
promiscuous targets
proteomics
pulmonary rehabilitation
Q203
rifampin
structure-based drug design
surgery
target
target identification
target-based drug design
target-based screening
TB
TBVI
toxicity
transcriptomics
tuberculosis
tuberculosis treatment
tuberculosis vaccines
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557627203321
Riccardi Giovanna  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui